Literature DB >> 107450

A trial of minocycline given after exposure to prevent gonorrhea.

W O Harrison, R R Hooper, P J Wiesner, A F Campbell, W W Karney, G H Reynolds, O G Jones, K K Holmes.   

Abstract

In a prospective evaluation of antibiotic prophylaxis against gonorrhea, 1080 men were given 200 mg of oral minocycline or placebo after sexual intercourse with prostitutes in a Far Eastern port. Later, at sea, gonococcal infection was detected in 57 of 565 men given placebo and 24 of 515 men given minocycline (P less than 0.001). Minocycline prophylaxis completely prevented infection by gonococci susceptible to 0.75 microgram or less of tetracycline per milliliter, reduced the risk of infection or prolonged the incubation period in men exposed to gonococci susceptible to 1.0 to 2.0 micrograms per milliliter, but did not prevent infection or prolong incubation in men exposed to gonococci resistant to 2.0 micrograms. Minocycline did not increase the proportion of asymptomatic infections. Minocycline prophylaxis would probably have limited effectiveness as a public-health measure because of the tendency to select resistant gonococci.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 107450     DOI: 10.1056/NEJM197905103001903

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  20 in total

1.  Preventing the spread of HIV infection.

Authors:  P D French; D E Mercey; D R Tomlinson; J R Harris
Journal:  BMJ       Date:  1991-04-20

2.  In vitro antibiotic susceptibilities of Neisseria gonorrhoeae isolates in the Philippines.

Authors:  T E Clendennen; C S Hames; E S Kees; F C Price; W J Rueppel; A B Andrada; G E Espinosa; G Kabrerra; F S Wignall
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

3.  Gonorrhoea in men: clinical and diagnostic aspects.

Authors:  J Sherrard; D Barlow
Journal:  Genitourin Med       Date:  1996-12

Review 4.  The repertoire of human efforts to avoid sexually transmissible diseases: past and present. Part 2: Strategies used during or after sex.

Authors:  B Donovan
Journal:  Sex Transm Infect       Date:  2000-04       Impact factor: 3.519

Review 5.  Drug therapies for sexually transmitted diseases. Clinical and economic considerations.

Authors:  W R Bowie
Journal:  Drugs       Date:  1995-04       Impact factor: 9.546

6.  The transmission dynamics of gonorrhoea: modelling the reported behaviour of infected patients from Newark, New Jersey.

Authors:  G P Garnett; K J Mertz; L Finelli; W C Levine; M E St Louis
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-04-29       Impact factor: 6.237

Review 7.  Randomized controlled trials of interventions to prevent sexually transmitted infections: learning from the past to plan for the future.

Authors:  Catherine M Wetmore; Lisa E Manhart; Judith N Wasserheit
Journal:  Epidemiol Rev       Date:  2010-06-02       Impact factor: 6.222

8.  Investigating ethnic inequalities in the incidence of sexually transmitted infections: mathematical modelling study.

Authors:  K M E Turner; G P Garnett; A C Ghani; J A C Sterne; N Low
Journal:  Sex Transm Infect       Date:  2004-10       Impact factor: 3.519

Review 9.  Antimicrobial susceptibility testing of Neisseria gonorrhoeae and implications for epidemiology and therapy.

Authors:  T Fekete
Journal:  Clin Microbiol Rev       Date:  1993-01       Impact factor: 26.132

10.  Whole-genome sequencing to determine transmission of Neisseria gonorrhoeae: an observational study.

Authors:  Dilrini De Silva; Joanna Peters; John Paul; David W Eyre; Kevin Cole; Michelle J Cole; Fiona Cresswell; Gillian Dean; Jayshree Dave; Daniel Rh Thomas; Kirsty Foster; Alison Waldram; Daniel J Wilson; Xavier Didelot; Yonatan H Grad; Derrick W Crook; Tim Ea Peto; A Sarah Walker
Journal:  Lancet Infect Dis       Date:  2016-07-12       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.